AI In Precision Medicine Market | Exploring Current Trends and Growth Status for | 2025-2033

AI In Precision Medicine Market report, published by DataM Intelligence, delivers detailed insights and analysis on major market trends, growth prospects, and emerging challenges. With a strong focus on providing actionable intelligence, DataM Intelligence enables businesses to make well-informed decisions and maintain a competitive edge. By blending both qualitative and quantitative research approaches, the company offers thorough reports that support clients in navigating complex market environments, driving strategic expansion, and capitalizing on new opportunities in today's rapidly evolving global landscape.

AI in Precision Medicine Market reached US$ 1,703.19 Million in 2024 and is expected to reach US$ 6,587.30 Million by 2033, growing at a CAGR of 38.7 % during the forecast period of 2025-2033.

Request a Free Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/ai-in-precision-medicine-market?sv

Market opportunities and Growth Drivers:

Advancements in AI, such as deep learning and machine learning, are driving growth in precision medicine by enabling faster, more accurate analysis of patient data for personalized treatment. Innovations like Google's TxGemma and Siemens' AI-driven neuroimaging tools are further accelerating the field.
However, data privacy and security concerns, including the risk of unauthorized data access and breaches, pose significant challenges. Fragmented regulations and past data misuse incidents highlight the need for stronger data protection measures to ensure trust and market growth.

AI In Precision Medicine Market Recent Development:

In April 2025, Illumina Inc. and Tempus AI, Inc. announced a strategic collaboration aimed at advancing the clinical adoption of next-generation sequencing (NGS) technologies. This partnership will leverage Illumina's cutting-edge AI capabilities alongside Tempus's robust multimodal data platform to develop and train genomic algorithms.

In January 2025, Guardant Health and ConcertAI announced a collaboration to provide biopharmaceutical companies with the industry's first multi-modal real-world data (RWD) solution that combines comprehensive patient electronic medical record (EMR) data with both genomic and epigenomic tumor profiling across all stages of cancer care.

List of the Key Players in the AI In Precision Medicine Market:

IBM Corporation, Microsoft Corporation, AstraZeneca, Sanofi, GE Healthcare, Intel Corporation, NVIDIA Corporation, Alphabet Inc, BioXcel Therapeutics Inc, Enlitic Inc & others.

Assessing the Effects of U.S. Tariffs on the AI In Precision Medicine Market

The U.S. tariff war is reshaping how businesses analyze trends and make strategic decisions. As tariffs drive up costs and disrupt supply chains, companies are increasingly focused on understanding consumer behavior, identifying new sourcing opportunities, and adjusting their operations to remain competitive. The ongoing uncertainty has created a stronger demand for timely insights and data-driven strategies to navigate shifting trade dynamics and economic pressures.

Research Process:

Both primary and secondary data sources have been used in the global AI In Precision Medicine Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://datamintelligence.com/enquiry/ai-in-precision-medicine-market?sv

Segment Covered in the AI In Precision Medicine Market:

By Technology: Deep Learning, Querying Method, Natural Language Processing, Context Aware Processing.

By Component: Hardware, Software, Services.

By Application: Oncology, Cardiology, Neurology, Respiratory.

Regional Analysis for AI In Precision Medicine Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

People Also Ask:

Most Frequently Asked Questions in the AI In Precision Medicine Market Research Industry:
➠ What are the global figures for sales, production, consumption, imports, and exports in the AI In Precision Medicine market?
➠ Who are the top manufacturers in the global AI In Precision Medicine industry, and what is their current status in terms of production capacity, output, sales performance, pricing structure, cost analysis, profit margins, and overall revenue?
➠ What key opportunities are available for vendors in the AI In Precision Medicine market, and what challenges are they likely to encounter?
➠ Which application areas, end-user segments, or product types are projected to experience significant growth, and how is the market share distributed among them?
➠ What are the major drivers and barriers influencing the growth trajectory of the AI In Precision Medicine market?
➠ What are the primary sales, marketing, and distribution strategies used across the global AI In Precision Medicine industry landscape?

Browse More Reports:https://datamintelligence.com/research-report/ai-in-precision-medicine-market?sv

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.